Company Of The Day: Boston Scientific

+6.13%
Upside
46.20
Market
49.03
Trefis
BSX: Boston Scientific logo
BSX
Boston Scientific

What?

Boston Scientific (NYSE:BSX) closed its acquisition of Baylis Medical, a company that offers advanced transseptal access solutions and products used to support heart procedures.

Why?

Relevant Articles
  1. Is There Room For Growth In Boston Scientific Stock?
  2. Will Boston Scientific Stock Rise Post Q3 Results?
  3. What To Expect From Boston Scientific Stock Following Q2 Earnings?
  4. Should You Buy Boston Scientific Stock At $38?
  5. What’s Happening With Boston Scientific Stock?
  6. What To Expect From Boston Scientific Stock Following Q1 Earnings?

With the $1.75 billion deal, Boston Scientific will be able to strengthen its position in multiple high-growth cardiology markets.

So What?

We think BSX stock is undervalued at current levels. We value BSX at about $50 per share, about 15% ahead of the current market price.

See Our Complete Analysis For Boston Scientific

What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since the end of 2016.

Returns Feb 2022
MTD [1]
2022
YTD [1]
2017-22
Total [2]
 BSX Return 3% 4% 104%
 S&P 500 Return -1% -6% 100%
 Trefis MS Portfolio Return 2% -8% 264%

[1] Month-to-date and year-to-date as of 2/17/2022
[2] Cumulative total returns since the end of 2016

Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates